Abiopharma

Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference

How the SWE ECP AG Helped With My Communication Anxiety

KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease

Valneva SE ADR (VALN) Files Form 6-K

Tentative approval of ANDA #ANDA #218472 for NINTEDANIB. Decision date: 01/07/2026

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT)

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth

New Form SCHEDULE 13G/A - Stevanato Group S.p.A. Filed: 2026-01-09 AccNo: 0001163744-26-000008 Size: 8 KB

New Form SCHEDULE 13G/A - LEMAITRE VASCULAR INC Filed: 2026-01-09 AccNo: 0001163744-26-000007 Size: 6 KB

A New Press Release from Oncolytics Biotech, Inc

New Form 425 - ONCOLYTICS BIOTECH INC Filed: 2026-01-09 AccNo: 0001104659-26-002348 Size: 1 MB

(99% Neutral) Pulse Biosciences, Inc. (PLSE) Files Form 8-K

(70% Positive) Autonomix Medical, Inc. (AMIX) Provides Update on treated for severe pancreatic cancer-related pain

(90% Positive) RHYTHM PHARMACEUTICALS, INC. (RYTM) Announces Enrollment Update for million Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment